FolioLanternBeta
TMOThermo Fisher Scientific

Marc Casper

Chairman & CEO, Director at Thermo Fisher Scientific, as of Sep 1, 2026Sold $53.9M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
139K
shares held after the latest filing, Thermo Fisher Scientific
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
94K
shares sold, past 12 months
11
days with sales
$9.8M
largest single day, Oct 24, 2025
4
companies filed for

Share of stake sold at Thermo Fisher Scientific is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $13.9M under a disclosed planOctNovDecJanFebMar 2026: $7.1M under a disclosed planMarAprMayJunJulAug 2026: $32.8M under a disclosed plan$32.8MAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Thermo Fisher Scientific (TMO)Chairman & CEO, DirectorNov 21, 2003Sep 1, 2026
Synopsys (SNPS)Former DirectorMay 25, 2022Apr 12, 2024
U.S. Bancorp (USB)Former DirectorApr 25, 2016Dec 23, 2020
Zimmer Biomet (ZBH)Former DirectorApr 2, 2009Apr 2, 2013

Also a director at

Synopsys (SNPS) (no filing in the last 18 months), U.S. Bancorp (USB) (no filing in the last 18 months), Zimmer Biomet (ZBH) (no filing in the last 18 months)

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.